SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
6.04
-0.25 (-3.97%)
Dec 20, 2024, 4:00 PM EST - Market closed

SBC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Revenue
223.34193.54174.16
Revenue Growth (YoY)
28.24%11.13%-
Cost of Revenue
57.856.2482.16
Gross Profit
165.55137.392
Selling, General & Admin
62.464.3370.09
Other Operating Expenses
0.772.311.54
Operating Expenses
75.9766.6471.63
Operating Income
89.5870.6620.37
Interest Expense
-0.02-0.05-0.03
Interest & Investment Income
0.040.090.47
Other Non Operating Income (Expenses)
-0.982.653.88
EBT Excluding Unusual Items
88.6173.3624.69
Impairment of Goodwill
---0.25
Gain (Loss) on Sale of Investments
-1.460.22-0.76
Pretax Income
90.9673.5823.68
Income Tax Expense
36.5935.0218.12
Earnings From Continuing Operations
54.3738.565.55
Minority Interest in Earnings
0.050.810.76
Net Income
54.4239.376.32
Net Income to Common
54.4239.376.32
Net Income Growth
761.71%523.44%-
Shares Outstanding (Basic)
888
Shares Outstanding (Diluted)
888
Shares Change (YoY)
2.86%--
EPS (Basic)
6.664.950.79
EPS (Diluted)
6.664.950.79
EPS Growth
737.76%523.44%-
Free Cash Flow
46.1841.15-24.99
Free Cash Flow Per Share
5.655.18-3.14
Gross Margin
74.12%70.94%52.83%
Operating Margin
40.11%36.51%11.70%
Profit Margin
24.36%20.34%3.63%
Free Cash Flow Margin
20.67%21.26%-14.35%
EBITDA
9582.9126.3
EBITDA Margin
42.54%42.84%15.10%
D&A For EBITDA
5.4312.255.93
EBIT
89.5870.6620.37
EBIT Margin
40.11%36.51%11.70%
Effective Tax Rate
40.23%47.59%76.55%
Revenue as Reported
223.34193.54174.16
Advertising Expenses
-3.376.57
Source: S&P Capital IQ. Standard template. Financial Sources.